Investing
624 Articles
The three major U.S. stock indexes opened lower this morning and remained in negative territory all day. The decline is…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday.…
Eli Lilly & Co. (NYSE: LLY) is confirming prior news showing that late-stage trial data analysis showed the the primary endpoints…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Wednesday.…
The three major U.S. stock indexes opened flat to higher this morning but picked up some buying steam after the…
Jon OggThese are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St. research calls…
Drugmaker Eli Lilly & Co. (NYSE: LLY) announced this morning that the company’s solanezumab treatment for Alzheimer’s disease failed to…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall St. research calls this Monday…
The three major US stock indexes opened mixed this morning with the Nasdaq Composite slightly negative on an unexpectedly weak…
Surging growth of its Cymbalta depression treatment helped Eli Lilly & Co. (NYSE: LLY) beat Wall St.’s earnings expectations. But…
The three major US stock indexes opened roughly flat this morning as Spanish 10-year bond yields rose to 7.5% and…
A new treatment for Alzheimer’s disease from Pfizer Inc. (NYSE: PFE) and partner Elan Corp. plc (NYSE: ELN) has failed…
Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…
Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…
GlobeImmune, Inc. is the latest biotech to file for an initial public offering. Financial terms were not disclosed but the…
Our top personal finance-related articles today. Your wallet will thank you later.